Thank you! We're honored to have our work recognized. UPMC sponsorship and support are invaluable in advancing innovative solutions like our precision approach to treat and diagnose serious infections. @RCSI_Irl@RCSI_Research
It was our pleasure to sponsor this award and recognise the work of @Intheliatx to develop an innovative bio marker-guided, host-targeted therapy to treat serious infection. Academics meets innovation to deliver transformative precision therapies and improved patient care. ๐๐ป๐๐ป
๐ Big announcement! ๐ Introducing the new #IntheliaTherapeutics website โ your gateway to groundbreaking innovations in the global fight against infection and #sepsis. Go to https://t.co/kOSBxxkYmF to explore! ๐๐ก #IntheliaTherapeutics@RCSI_Research
Delighted to be shortlisted for the Innovation Award at the @HealthIreland 2024. Inthelia is a cutting-edge biopharmaceutical company focused on transforming the landscape of precision medicine in infection. @SteveWKerrigan@RCSI_Irl@RCSIPharmBioMol
Professor @SteveWKerrigan from @RCSIPharmBioMol has been researching #sepsis for 25 years.
In this piece for #WorldSepsisDay he speaks to RTร News about raising awareness of the illness and how it is caused.
โฌ๏ธ https://t.co/UUaXDkjrRc